Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ohbayashi (Mizunami, Japan). Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma. Eur Respir J 2014; 44: Suppl. 58, 2428

Member's Comments

No comment yet.

Related content which might interest you: Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airway Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Atomization inhalation on the NO content in the airway of patients with bronchial asthma Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases Year: 2016 Efficacy of carbamazepine in treatment of bronchial asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 B2-adrenoceptor genotype16 influences airway calibre but not hyperresponsiveness in asthmatics using regular B2-agonist in addition to inhaled corticosteroids Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Are ultrafine particle inhalers, better for patients with small airway involvement? Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Effects of inhaled salmeterol/fluticasone on lung function in patients with bronchiectasis Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013 HDM sublingual AIT tablet is well-tolerated and effective in partly and uncontrolled allergic asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Airway hyperresponsiveness in patients treated with omalizumab Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Lung deposition analysis of two formulations of fluticasone/salmeterol HFA pMDI in stable asthma patients Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014